Bill Few Associates Inc. Has $389,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bill Few Associates Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 769 shares of the healthcare conglomerate’s stock after selling 250 shares during the quarter. Bill Few Associates Inc.’s holdings in UnitedHealth Group were worth $389,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in UNH. APG Asset Management US Inc. grew its holdings in shares of UnitedHealth Group by 5.3% in the 2nd quarter. APG Asset Management US Inc. now owns 351,983 shares of the healthcare conglomerate’s stock valued at $174,108,000 after acquiring an additional 17,747 shares in the last quarter. Ameriprise Financial Inc. grew its stake in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after purchasing an additional 21,149 shares in the last quarter. Employees Retirement System of Texas raised its stake in shares of UnitedHealth Group by 9.2% during the 2nd quarter. Employees Retirement System of Texas now owns 198,670 shares of the healthcare conglomerate’s stock worth $101,175,000 after purchasing an additional 16,800 shares in the last quarter. Eminence Capital LP bought a new position in shares of UnitedHealth Group in the second quarter valued at $26,657,000. Finally, Drucker Wealth 3.0 LLC bought a new stake in UnitedHealth Group during the second quarter worth $1,062,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, TD Cowen raised their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $627.74.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $528.94 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $486.77 billion, a P/E ratio of 34.12, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a fifty day simple moving average of $543.52 and a 200 day simple moving average of $563.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.